ID: ALA4642294

Max Phase: Preclinical

Molecular Formula: C24H26O4

Molecular Weight: 378.47

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(O)[C@H]1C[C@@H]1CCC12CCC(c3cccc(Oc4ccccc4)c3)(CC1)O2

Standard InChI:  InChI=1S/C24H26O4/c25-22(26)21-15-17(21)9-10-23-11-13-24(28-23,14-12-23)18-5-4-8-20(16-18)27-19-6-2-1-3-7-19/h1-8,16-17,21H,9-15H2,(H,25,26)/t17-,21-,23?,24?/m0/s1

Standard InChI Key:  SNDBIMFUTZHJHS-QQIMVSQYSA-N

Associated Targets(Human)

FFAR4 Tchem G-protein coupled receptor 120 (2999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ffar4 Omega-3 fatty acid receptor 1 (147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 378.47Molecular Weight (Monoisotopic): 378.1831AlogP: 5.52#Rotatable Bonds: 7
Polar Surface Area: 55.76Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.25CX Basic pKa: CX LogP: 4.94CX LogD: 1.94
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.69Np Likeness Score: 0.64

References

1. Dowarah J, Singh VP..  (2020)  Anti-diabetic drugs recent approaches and advancements.,  28  (5): [PMID:32008883] [10.1016/j.bmc.2019.115263]
2. Kerru N, Singh-Pillay A, Awolade P, Singh P..  (2018)  Current anti-diabetic agents and their molecular targets: A review.,  152  [PMID:29751237] [10.1016/j.ejmech.2018.04.061]

Source